84 related articles for article (PubMed ID: 9156660)
1. N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis.
De Melo MB; Lorand-Metze I; Lima CS; Saad ST; Costa FF
Leuk Lymphoma; 1997 Jan; 24(3-4):309-17. PubMed ID: 9156660
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.
Melo MB; Ahmad NN; Lima CS; Pagnano KB; Bordin S; Lorand-Metze I; SaAd ST; Costa FF
Hematology; 2002 Feb; 7(1):13-9. PubMed ID: 12171773
[TBL] [Abstract][Full Text] [Related]
3. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation.
Bühler-Leclerc M; Gratwohl A; Senn HP
Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.
Elghannam DM; Abousamra NK; Shahin DA; Goda EF; Azzam H; Azmy E; El-Din MS; El-Refaei MF
Egypt J Immunol; 2009; 16(1):9-15. PubMed ID: 20726318
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.
Andersson A; Johansson B; Lassen C; Mitelman F; Billström R; Fioretos T
Eur J Haematol; 2004 May; 72(5):307-13. PubMed ID: 15059064
[TBL] [Abstract][Full Text] [Related]
7. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia.
Preston R; Däbritz J; Hänfler J; Oettle H
Leuk Res; 2010 Jul; 34(7):883-91. PubMed ID: 20304488
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia.
Ritter M; Kim TD; Lisske P; Thiede C; Schaich M; Neubauer A
Haematologica; 2004 Nov; 89(11):1397-9. PubMed ID: 15531466
[TBL] [Abstract][Full Text] [Related]
10. ras oncogene activation and occupational exposures in acute myeloid leukemia.
Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ras gene mutations in childhood myeloid leukaemia.
Farr C; Gill R; Katz F; Gibbons B; Marshall CJ
Br J Haematol; 1991 Mar; 77(3):323-7. PubMed ID: 2012756
[TBL] [Abstract][Full Text] [Related]
12. High incidence of conservative RAS mutations in acute myeloid leukemia.
Aurer I; Labar B; Nemet D; Ajduković R; Bogdanić V; Gale RP
Acta Haematol; 1994; 92(3):123-5. PubMed ID: 7871950
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
[TBL] [Abstract][Full Text] [Related]
14. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA
Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308
[TBL] [Abstract][Full Text] [Related]
15. Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemia.
Inokuchi K; Yamaguchi H; Hanawa H; Tanosaki S; Nakamura K; Tarusawa M; Miyake K; Shimada T; Dan K
Clin Cancer Res; 2002 Jun; 8(6):1882-8. PubMed ID: 12060632
[TBL] [Abstract][Full Text] [Related]
16. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC
Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387
[TBL] [Abstract][Full Text] [Related]
17. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
Roumier C; Lejeune-Dumoulin S; Renneville A; Goethgeluck AS; Philippe N; Fenaux P; Preudhomme C
Leukemia; 2006 Mar; 20(3):433-6. PubMed ID: 16424869
[TBL] [Abstract][Full Text] [Related]
19. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Tocharoentanaphol C
Eur J Haematol; 2006 Jul; 77(1):51-6. PubMed ID: 16573741
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
